About Serigen
Serigen is a Healthcare company based in Pune (India) founded in 2015 by Swati Shukla, Anuya Nisal, and Premnath Venugopalan. Serigen has raised $3.63 million across 6 funding rounds from investors including BioAngels, Sparrow Technologies and Indian Angel Network. Serigen was last valued at $7.86 million in March 2023. Its chief executive, as recorded, is Anuya Nisal. Its Indian entity Serigen Mediproducts Private Limited reported revenue of ₹91.1 Lakh. Serigen offers products and services including Serioss, Seriderm, and Serimat. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices.
Company details
Developer of protein-based tissue regeneration products for orthopedics. It uses natural silk proteins to develop tissue regeneration products such as Serioss for bone tissue repair, Serimat for soft tissue regeneration, and Seriderm for wound healing.
- Headquarters Pune, India
- Founders Swati Shukla, Anuya Nisal, Premnath Venugopalan
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website serigenmed.com
- Social LinkedIn X YouTube
- Legal Name Serigen Mediproducts Private Limited
- Date of Incorporation 03 Feb, 2015
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹91.1 Lakh
FY 2025 · +338% YoY
- Net Loss-₹3.41 Cr
FY 2025 · -374% margin
- EBITDA-₹3.25 Cr
FY 2025 · -357% margin
- Total Equity Funding$3.63M (USD)
in 6 rounds
- Latest Funding Round$1.07M (USD), Seed
Mar 2026
- InvestorsBioAngels
& 46 more
Associated legal entities of Serigen
Serigen operates through Serigen Mediproducts Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Serigen Mediproducts Private Limited CIN U74900PN2015PTC153912 | Active | 03 Feb 2015 | Pune, Maharashtra | ₹0.9 Cr | 29 | 5 | View details |
Products & Services of Serigen
Serigen offers a comprehensive portfolio of products and services, including Serioss, Seriderm, and Serimat.
Osteoconductive filler for bone cavities caused by trauma or infection.
Absorbent dressing that accelerates healing of diabetic ulcers and burns.
Engineered matrix for promoting regeneration of soft tissues.
Apps and channels of Serigen
its YouTube channel Serigen Mediproducts has 15 subscribers and 8 videos.
Videos from Serigen
The most watched videos on Serigen's YouTube channel, Serigen Mediproducts (15 subscribers). Click a video to play it here.
More on Serigen Mediproducts.
Funding Insights of Serigen
Serigen has successfully raised a total of $3.63M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $1.07 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.63M
- Total Rounds 6
- Last Round Seed — $1.07M
- First Round $423,273
(Jan 2020)
- Investors Count 47
All 6 funding rounds of Serigen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2026 | $1.07M | Seed | – | Indian Angel Network | |
| Sep 2025 | $224,959 | Seed | – | Indian Angel Network | – |
| Aug 2024 | $1.19M | Seed | – | Indian Angel Network, Colossa Ventures | – |
| Mar 2023 | $284,500 | Seed | $7.86M | BioAngels | |
| Jul 2022 | $433,400 | Seed | $7.74M | – | |
| Jan 2020 | $423,273 | Seed | $••••• | Pandit Nominees |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2023 | $7.86M | •••••••• |
| Jul 2022 | $7.74M | •••••••• |
| Jan 2020 | $••••• | •••••••• |
Full valuation and stage history of Serigen
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $7.86M (Mar 2023). 47 investors in total: 8 institutional and 39 angel.
Investors in Serigen
Serigen has secured backing from 47 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include BioAngels, Sparrow Technologies and Indian Angel Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Angel investor network investing in early-stage startups | iangroup.vc | Delhi, India | ||
Investments are directed by Colossa Ventures toward diverse tech sectors. | colossaventures.com | |||
Investment and support platform for biotech and related startups in India. | 2022 | bioangels.vc | Delhi, India | |
Early-stage investments are targeted by Jaithirth Rao Trust. | ||||
Multiple-stage venture capital investments are managed by Haystack. | haystack.vc | Menlo Park, United States | ||
High-precision injection moulded components and assemblies are manufactured. | 1994 | sparrowit.com | Bengaluru, India | |
SD Shantanu Deshpande | Founder & CEO of Bombay Shaving Company, active angel investor | unknown_5fd032d68a724dd69 | ||
AD Anand Deshpande | Founder of Persistent Systems, active angel investor in Indian startups | unknown_934e362494b24dcaa | ||
SD Sanjay Dalmia | Indian industrialist, angel investor, and Chairman of Dalmia Group of Companies. | unknown_975d9b5278d848f39 |
Investor details for Serigen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Serigen Mediproducts Private Limited (Serigen)
Serigen Mediproducts Private Limited is the primary company behind Serigen. The board of Serigen Mediproducts Private Limited currently have 5 directors; the longest-serving is Anuya Amol Nisal, appointed in 2015. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anuya Amol Nisal DIN 07058985 | Director | 03 Feb 2015 | 11 yrs 8 mo | Serigen Mediproducts Private Limited |
| Premnath Venugopalan DIN 00895347 | Director | 03 Feb 2015 | 11 yrs 8 mo | Serigen Mediproducts Private Limited |
| Priti Jay Rao DIN 03352049 | Director | 15 Jan 2020 | 6 yrs 9 mo | Serigen Mediproducts Private Limited |
| Sarika Saxena DIN 07667623 | Nominee Director | 05 Sep 2024 | 2 yrs 1 mo | Serigen Mediproducts Private Limited |
| Swati Govind Shukla DIN 10769263 | Director | 05 Sep 2024 | 2 yrs 1 mo | Serigen Mediproducts Private Limited |
People of Serigen
3 people are tracked at Serigen (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder & CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Serigen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Serigen
Figures of Serigen Mediproducts Private Limited, the primary company behind Serigen, for FY 2025. Revenue was ₹91.1 Lakh (+338% year on year). Net loss was -₹3.41 Cr (-374% margin). EBITDA was -₹3.25 Cr (-357% margin). Revenue has grown at a compounded annual rate of +13% over three years and +76% over five years.
- ₹91.1 LakhRevenue · FY 2025 · +338% YoY
- -₹3.41 CrNet loss · -374% margin
- -₹3.25 CrEBITDA · -357% margin
- ₹1.9 LakhPaid-up capital
- 29Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +76%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Serigen Mediproducts Private Limited are on its company page.
Detailed financial statements for Serigen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Serigen
4 dated milestones of Serigen across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Serigen is founded.
- Funding First funding round of $423K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $1.1M.
Web traffic of Serigen
The website of Serigen (serigenmed.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 40.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Serigen
Complete news archive for Serigen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serigen
Serigen was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Serigen is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Anuya Nisal is the CEO of Serigen, as recorded in our data. They have also founded this company.
Serigen is a funded company, having raised a total of $3.63M across 6 funding rounds to date. The company's 1st funding round was a Seed of $423.27K, raised on Jan 2020.
The primary company behind Serigen, Serigen Mediproducts Private Limited, reported revenue of ₹91.1 Lakh for FY 2025, up 338% year on year.
Developer of protein-based tissue regeneration products for orthopedics. It uses natural silk proteins to develop tissue regeneration products such as Serioss for bone tissue repair, Serimat for soft tissue regeneration, and Seriderm for wound healing.
Serigen offers Serioss, Seriderm, and Serimat.
Serigen has 47 investors. Key investors include BioAngels, Sparrow Technologies, Indian Angel Network, Colossa Ventures, and Shantanu Deshpande.
The valuation of Serigen is $7.86M as of Mar 2023.
Serigen operates through Serigen Mediproducts Private Limited.
The legal entities of Serigen currently have 5 directors, including Priti Jay Rao, Anuya Amol Nisal, Premnath Venugopalan and others.